TEVAR in complicated type B dissection: technical decisions that make the difference
This article summarizes the step-by-step TEVAR technique for complicated type B aortic dissection as described in the original study, and includes a final commentary where we integrate practical recommendations drawn from recent surgical articles, European guidelines, and the author’s own experience.
Document of consensus on the management of pulmonary atresia with intact ventricular septum
Consensus document from the Clinical Practice Standards Committee Working Group of the American Association for Thoracic Surgery on the management of pulmonary atresia with intact ventricular septum.
A Canadian in America: long-term outcomes of the Svensson modification of the David operation
Report on the very long-term outcomes (15 years) of a single-surgeon experience at the Cleveland Clinic with aortic root reimplantation surgery.
Transcarotid access for TAVR: sustained safety and efficacy at five years
Prospective observational study evaluating 5-year clinical outcomes of transcarotid TAVR in moderate-to-high surgical risk patients with no viable femoral access.
Management of Ebstein anomaly in children and adults: second part of the AATS consensus statement
Second part of the consensus guidelines regarding the treatment and management of Ebstein´s anomaly in children and adults
What can the US learn from the Spanish heart transplantation model?
Results from the US heart transplant program between 2016 and 2022, analyzing demographic characteristics, mortality, and 30-day readmissions in heart transplant recipients.
The reinvention of ECMO: strategies that break the VA/VV mold
Editorial commentary on novel cannulation strategies in extracorporeal membrane oxygenation (ECMO) recently published in the Journal of Cardiothoracic and Vascular Anesthesia, proposing technical alternatives to standard VA or VV-ECMO support. These alternative approaches may be particularly valuable in cases of complex pathophysiology, high cardiac output, right ventricular failure, or when conventional devices are contraindicated.
Evolution of mitral regurgitation after TAVI: functional improvement or marker of poor prognosis?
This retrospective observational study evaluated 2250 patients who underwent TAVI, comparing outcomes based on the presence or absence of significant (moderate or greater) concomitant mitral regurgitation (MR).
